Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Textual)

v2.4.0.8
RELATED PARTY TRANSACTIONS (Details Textual) (USD $)
3 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Aug. 31, 2014
Subsequent Event [Member]
Jul. 31, 2014
Subsequent Event [Member]
Jul. 11, 2014
Subsequent Event [Member]
Jun. 30, 2014
Common Stock [Member]
Aug. 01, 2013
Lederman Co [Member]
Jul. 31, 2013
Lederman Co [Member]
Jul. 31, 2013
Eli Lederman [Member]
Mar. 18, 2014
Leder Laboratories, Inc. [Member]
Intellectual Property [Member]
Common Stock [Member]
Mar. 18, 2014
Starling Pharmaceuticals, Inc. [Member]
Intellectual Property [Member]
Common Stock [Member]
Related Party Transaction [Line Items]                          
Related Party Transaction, Expenses from Transactions with Related Party $ 0 $ 62,500 $ 37,723 $ 125,000                  
Debt Instrument, Face Amount                 80,000 150,000 50,000    
Promissory Notes Exchange Price                 80,000 150,000 50,000    
Payments to Acquire Intangible Assets                       125,000 125,000
Stock Issued During Period, Shares, Purchase of Assets               50,000       25,000 25,000
Stock Issued During Period, Value, Purchase of Assets     608,000         0       303,750 303,750
Shares Issued, Price Per Share             $ 11.90         $ 12.15 $ 12.15
Repayment of Notes Receivable from Related Parties         $ 80,000 $ 200,000